Please assess the completion status of the following clinical trial:

Trial Title: Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age over 21 years~* able and agrees to drink alcohol~Exclusion Criteria:~* alcoholism (self-reported)~* pregnancy~* reactive airway disease~* diabetes~* kidney/bladder stones~* kidney disease~* liver disease~* stomach ulcer~* organ transplant patients~* dialysis patients~* allergies to alcohol, eggs, milk, or wheat~* volunteers taking the following medications: opiate pain medication, activated charcoal, ampicillin,carbamazepine, cephalosporidine, methicillin, nitroglycerine, oxacillin, penicillin G, quinicillin

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Healthy volunteers consume alcohol independently and estimate number of drinks then apply Vick's vapor rub under nose and take placebo capsules based on number of drinks consumed and fill out a Hangover Symptom Scale the next morning
- N-acetyl cysteine (Type: EXPERIMENTAL): Healthy volunteers consume alcohol independently and estimate number of drinks then apply Vick's vapor rub under nose and take N-Acetyl Cysteine capsules based on number of drinks consumed and fill out a Hangover Symptom Scale the next morning

Based on this trial design, predict the completion outcome and termination type (if applicable).